Interventional, pre-market, pivotal, double-blind, controlled clinical study to evaluate the safety and performance of Crosslinked Hyaluronic Acid (CLHA) Hydrogel (with and without lidocaine) for the treatment of soft tissue deficiencies.
Project objectivesSafety and performance evaluation of Crosslinked Hyaluronic Acid (CLHA) Hydrogel (with and without lidocaine) for the treatment of soft tissue deficiencies. |
Start and end date |
| March 2022 - Ongoing |
Project Manager |
| Prof. Paolo Persichetti (Principal Investigator) Prof. Giovanni Marangi (Co-Experimenter) Dr. Marco Gratteri (Co-Experimenter) |
Coordinating institution of the project |
| FPUCBM |
